Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Current medicinal chemistry ; h5-index 49.0

The current COVID-19 pandemic gave rise to an unprecedented response from clinicians and the scientific community in all relevant biomedical fields. This created an incredible multidimensional data-rich framework in which deep learning proved instrumental to make sense of the data and build models used in prediction-validation workflows that in a matter of months have already produced results in assessing the spread of the outbreak, its taxonomy, population susceptibility, in diagnostics or drug discovery and repurposing. More is expected to come in the near future from using such advanced machine learning techniques in combating this pandemic. This review is aimed to uncover just a small fraction of this large global endeavor by focusing on the research performed on the main COVID-19 targets, on the computational weaponry used in identifying drugs to combat the disease, and on some of the most important directions found in confronting COVID-19 or alleviating its symptoms in the absence of vaccines or specific medication.

Mernea Maria, Martin Eliza C, Petrescu Andrei-José, Avram Speranta

2021-Jan-13

SARS-CoV-2, deep learning, drug design, drug repurposing.\n, drug-target interactions, virtual screening